Loss of Epithelial Hypoxia-Inducible Factor Prolyl Hydroxylase 2 Accelerates Skin Wound Healing in Mice

REFERENCES

• Shaw TJ, Martin P. 2009. Wound repair at a glance. J. Cell Sci. 122:3209–3213.
   PubMed Web of Science ®Google Scholar
• Lowell CA, Mayadas TN. 2012. Overview: studying integrins in vivo. Methods Mol. Biol. 757:369–397.
   PubMedGoogle Scholar
• Gailit J, Welch MP, Clark RA. 1994. TGF-beta 1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. J. Invest. Dermatol. 103:221–227.
   PubMed Web of Science ®Google Scholar
• Reynolds LE, Conti FJ, Lucas M, Grose R, Robinson S, Stone M, Saunders G, Dickson C, Hynes RO, Lacy-Hulbert A, Hodivala-Dilke K. 2005. Accelerated re-epithelialization in beta3-integrin-deficient-mice is associated with enhanced TGF-beta1 signaling. Nat. Med. 11:167–174.
   PubMed Web of Science ®Google Scholar
• Grose R, Hutter C, Bloch W, Thorey I, Watt FM, Fassler R, Brakebusch C, Werner S. 2002. A crucial role of beta 1 integrins for keratinocyte migration in vitro and during cutaneous wound repair. Development 129:2303–2315.
   PubMed Web of Science ®Google Scholar
• Larjava H, Salo T, Haapasalmi K, Kramer RH, Heino J. 1993. Expression of integrins and basement membrane components by wound keratinocytes. J. Clin. Invest. 92:1425–1435.
   PubMed Web of Science ®Google Scholar
• Zambruno G, Marchisio PC, Marconi A, Vaschieri C, Melchiori A, Giannetti A, De Luca M. 1995. Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing. J. Cell Biol. 129:853–865.
   PubMed Web of Science ®Google Scholar
• Shattil SJ. 1995. Function and regulation of the beta 3 integrins in hemostasis and vascular biology. Thromb. Haemost. 74:149–155.
   PubMed Web of Science ®Google Scholar
• Hynes RO. 2009. The extracellular matrix: not just pretty fibrils. Science 326:1216–1219.
   PubMed Web of Science ®Google Scholar
• Moustakas A, Heldin CH. 2009. The regulation of TGFbeta signal transduction. Development 136:3699–3714.
   PubMed Web of Science ®Google Scholar
• Werner S, Grose R. 2003. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83:835–870.
   PubMed Web of Science ®Google Scholar
• Amendt C, Mann A, Schirmacher P, Blessing M. 2002. Resistance of keratinocytes to TGFbeta-mediated growth restriction and apoptosis induction accelerates re-epithelialization in skin wounds. J. Cell Sci. 115:2189–2198.
   PubMed Web of Science ®Google Scholar
• Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng C, Roberts AB. 1999. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat. Cell Biol. 1:260–266.
   PubMed Web of Science ®Google Scholar
• Lokmic Z, Musyoka J, Hewitson TD, Darby IA. 2012. Hypoxia and hypoxia signaling in tissue repair and fibrosis. Int. Rev. Cell Mol. Biol. 296:139–185.
   PubMed Web of Science ®Google Scholar
• Bedogni B, Welford SM, Cassarino DS, Nickoloff BJ, Giaccia AJ, Powell MB. 2005. The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation. Cancer Cell 8:443–454.
   PubMed Web of Science ®Google Scholar
• Varghese MC, Balin AK, Carter DM, Caldwell D. 1986. Local environment of chronic wounds under synthetic dressings. Arch. Dermatol. 122:52–57.
   PubMed Web of Science ®Google Scholar
• Ninikoski J, Heughan C, Hunt TK. 1972. Oxygen tensions in human wounds. J. Surg. Res. 12:77–82.
   PubMedGoogle Scholar
• Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DA, Bauer C, Gassmann M, Candinas D. 2001. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J. 15:2445–2453.
   PubMed Web of Science ®Google Scholar
• Rankin EB, Biju MP, Liu Q, Unger TL, Rha J, Johnson RS, Simon MC, Keith B, Haase VH. 2007. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J. Clin. Invest. 117:1068–1077.
   PubMed Web of Science ®Google Scholar
• Wiesener MS, Jurgensen JS, Rosenberger C, Scholze CK, Horstrup JH, Warnecke C, Mandriota S, Bechmann I, Frei UA, Pugh CW, Ratcliffe PJ, Bachmann S, Maxwell PH, Eckardt KU. 2003. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J. 17:271–273.
   PubMed Web of Science ®Google Scholar
• Rezvani HR, Ali N, Nissen LJ, Harfouche G, de Verneuil H, Taieb A, Mazurier F. 2011. HIF-1alpha in epidermis: oxygen sensing, cutaneous angiogenesis, cancer, and non-cancer disorders. J. Invest. Dermatol. 131:1793–1805.
   PubMed Web of Science ®Google Scholar
• Kaelin WGJr, Ratcliffe PJ. 2008. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30:393–402.
   PubMed Web of Science ®Google Scholar
• Maxwell PH, Ratcliffe PJ. 2002. Oxygen sensors and angiogenesis. Semin. Cell Dev. Biol. 13:29–37.
   PubMed Web of Science ®Google Scholar
• Takeda K, Ho VC, Takeda H, Duan LJ, Nagy A, Fong GH. 2006. Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2. Mol. Cell. Biol. 26:8336–8346.
   PubMed Web of Science ®Google Scholar
• Botusan IR, Sunkari VG, Savu O, Catrina AI, Grunler J, Lindberg S, Pereira T, Yla-Herttuala S, Poellinger L, Brismar K, Catrina SB. 2008. Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 105:19426–19431.
   PubMed Web of Science ®Google Scholar
• Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, Johnson RS. 2000. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res. 60:4010–4015.
   PubMed Web of Science ®Google Scholar
• Franke K, Kalucka J, Mamlouk S, Singh RP, Muschter A, Weidemann A, Iyengar V, Jahn S, Wieczorek K, Geiger K, Muders M, Sykes AM, Poitz DM, Ripich T, Otto T, Bergmann S, Breier G, Baretton G, Fong GH, Greaves DR, Bornstein S, Chavakis T, Fandrey J, Gassmann M, Wielockx B. 2013. HIF-1alpha is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2alpha-induced excessive erythropoiesis. Blood 121:1436–1445.
   PubMed Web of Science ®Google Scholar
• Hattori N, Mochizuki S, Kishi K, Nakajima T, Takaishi H, D'Armiento J, Okada Y. 2009. MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing. Am. J. Pathol. 175:533–546.
   PubMed Web of Science ®Google Scholar
• Hafner M, Wenk J, Nenci A, Pasparakis M, Scharffetter-Kochanek K, Smyth N, Peters T, Kess D, Holtkotter O, Shephard P, Kudlow JE, Smola H, Haase I, Schippers A, Krieg T, Muller W. 2004. Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte-expressed protein. Genesis 38:176–181.
   PubMedGoogle Scholar
• Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8:265–277.
   PubMed Web of Science ®Google Scholar
• Licht AH, Raab S, Hofmann U, Breier G. 2004. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice. Dev. Dyn. 229:312–318.
   PubMedGoogle Scholar
• Singh RP, Franke K, Kalucka J, Mamlouk S, Muschter A, Gembarska A, Grinenko T, Willam C, Naumann R, Anastassiadis K, Stewart AF, Bornstein S, Chavakis T, Breier G, Waskow C, Wielockx B. 10 May 2013. HIF-prolyl hydroxylase 2 (PHD2) is a critical regulator of hematopoietic stem cell maintenance during steady-state and stress. Blood [Epub ahead of print.] doi:10.1182/blood-2012-12-471185.
   Google Scholar
• Boutin AT, Weidemann A, Fu Z, Mesropian L, Gradin K, Jamora C, Wiesener M, Eckardt KU, Koch CJ, Ellies LG, Haddad G, Haase VH, Simon MC, Poellinger L, Powell FL, Johnson RS. 2008. Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell 133:223–234.
   PubMed Web of Science ®Google Scholar
• Rezvani HR, Ali N, Serrano-Sanchez M, Dubus P, Varon C, Ged C, Pain C, Cario-Andre M, Seneschal J, Taieb A, de Verneuil H, Mazurier F. 2011. Loss of epidermal hypoxia-inducible factor-1alpha accelerates epidermal aging and affects re-epithelialization in human and mouse. J. Cell Sci. 124:4172–4183.
   PubMed Web of Science ®Google Scholar
• Keely S, Glover LE, MacManus CF, Campbell EL, Scully MM, Furuta GT, Colgan SP. 2009. Selective induction of integrin beta1 by hypoxia-inducible factor: implications for wound healing. FASEB J. 23:1338–1346.
   PubMed Web of Science ®Google Scholar
• Cowden Dahl KD, Robertson SE, Weaver VM, Simon MC. 2005. Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression. Mol. Biol. Cell 16:1901–1912.
   PubMed Web of Science ®Google Scholar
• Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA. 1994. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157–1164.
   PubMed Web of Science ®Google Scholar
• Amendt C, Schirmacher P, Weber H, Blessing M. 1998. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development. Oncogene 17:25–34.
   PubMedGoogle Scholar
• Frank S, Madlener M, Werner S. 1996. Transforming growth factors beta1, beta2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing. J. Biol. Chem. 271:10188–10193.
   PubMed Web of Science ®Google Scholar
• Faler BJ, Macsata RA, Plummer D, Mishra L, Sidawy AN. 2006. Transforming growth factor-beta and wound healing. Perspect. Vasc. Surg. Endovasc. Ther. 18:55–62.
   PubMedGoogle Scholar
• Rahimi RA, Leof EB. 2007. TGF-beta signaling: a tale of two responses. J. Cell. Biochem. 102:593–608.
   PubMed Web of Science ®Google Scholar
• Tatti O, Vehvilainen P, Lehti K, Keski-Oja J. 2008. MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1. Exp. Cell Res. 314:2501–2514.
   PubMed Web of Science ®Google Scholar
• Wang M, Zhao D, Spinetti G, Zhang J, Jiang LQ, Pintus G, Monticone R, Lakatta EG. 2006. Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall. Arterioscler. Thromb. Vasc. Biol. 26:1503–1509.
   PubMed Web of Science ®Google Scholar
• Singer AJ, Clark RA. 1999. Cutaneous wound healing. N. Engl. J. Med. 341:738–746.
   PubMed Web of Science ®Google Scholar
• Biswas S, Roy S, Banerjee J, Hussain SR, Khanna S, Meenakshisundaram G, Kuppusamy P, Friedman A, Sen CK. 2010. Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proc. Natl. Acad. Sci. U. S. A. 107:6976–6981.
   PubMed Web of Science ®Google Scholar
• Elson DA, Ryan HE, Snow JW, Johnson R, Arbeit JM. 2000. Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res. 60:6189–6195.
   PubMed Web of Science ®Google Scholar
• Elson DA, Thurston G, Huang LE, Ginzinger DG, McDonald DM, Johnson RS, Arbeit JM. 2001. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev. 15:2520–2532.
   PubMed Web of Science ®Google Scholar
• Kong T, Eltzschig HK, Karhausen J, Colgan SP, Shelley CS. 2004. Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression. Proc. Natl. Acad. Sci. U. S. A. 101:10440–10445.
   PubMed Web of Science ®Google Scholar
• Dvorak HF. 1986. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315:1650–1659.
   PubMed Web of Science ®Google Scholar
• Schäfer M, Werner S. 2008. Cancer as an overhealing wound: an old hypothesis revisited. Nat. Rev. Mol. Cell Biol. 9:628–638.
   PubMed Web of Science ®Google Scholar
• Kremser ME, Przybylo M, Hoja-Lukowicz D, Pochec E, Amoresano A, Carpentieri A, Bubka M, Litynska A. 2008. Characterisation of alpha3beta1 and alpha (v) beta3 integrin N-oligosaccharides in metastatic melanoma WM9 and WM239 cell lines. Biochim. Biophys. Acta 1780:1421–1431.
   PubMedGoogle Scholar
• Hudson LG, Gale JM, Padilla RS, Pickett G, Alexander BE, Wang J, Kusewitt DF. 2010. Microarray analysis of cutaneous squamous cell carcinomas reveals enhanced expression of epidermal differentiation complex genes. Mol. Carcinog. 49:619–629.
   PubMedGoogle Scholar
• Jeanes AI, Wang P, Moreno-Layseca P, Paul N, Cheung J, Tsang R, Akhtar N, Foster FF, Brennan K, Streuli CH. 2012. Specific beta-containing integrins exert differential control on proliferation and 2D collective cell migration in mammary epithelial cells. J. Biol. Chem. 287:24103–24112.
   PubMedGoogle Scholar
• Arwert EN, Hoste E, Watt FM. 2012. Epithelial stem cells, wound healing and cancer. Nat. Rev. Cancer 12:170–180.
   PubMed Web of Science ®Google Scholar
• Diaz-Gonzalez F, Forsyth J, Steiner B, Ginsberg MH. 1996. Trans-dominant inhibition of integrin function. Mol. Biol. Cell 7:1939–1951.
   PubMed Web of Science ®Google Scholar
• Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM. 2002. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat. Med. 8:27–34.
   PubMed Web of Science ®Google Scholar